Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Phase II trial of preoperative chemoradiotherapy followed by surgical resection in patients with superior sulcus non-small-cell lung cancers: report of Japan Clinical Oncology Group trial 9806.

Kunitoh H, Kato H, Tsuboi M, Shibata T, Asamura H, Ichinose Y, Katakami N, Nagai K, Mitsudomi T, Matsumura A, Nakagawa K, Tada H, Saijo N; Japan Clinical Oncology Group.

J Clin Oncol. 2008 Feb 1;26(4):644-9. doi: 10.1200/JCO.2007.14.1911. Erratum in: J Clin Oncol. 2011 Nov 20;29(33):4472. Ichonose, Yukito [corrected to Ichinose, Yukito].

PMID:
18235125
2.

[The effect of multimodality induction therapy for locally advanced non-small cell lung cancer].

Yamada T, Nakashima Y, Tanahashi M, Hikosaka Y, Yoshitomi H, Niwa H.

Kyobu Geka. 2005 Oct;58(11):969-75. Japanese.

PMID:
16235845
3.

Postoperative adjuvant therapy for stage II non-small-cell lung cancer.

Park JH, Shim YM, Baek HJ, Kim MS, Choe DH, Cho KJ, Lee CT, Zo JI.

Ann Thorac Surg. 1999 Nov;68(5):1821-6.

PMID:
10585065
4.

Induction chemotherapy employing dose-intense cisplatin with mitomycin and vinblastine (MVP400), followed by thoracic surgery or irradiation, for patients with stage III nonsmall cell lung carcinoma.

Ng KK, Kris MG, Ginsberg RJ, Heelan RT, Pisters KM, Miller VA, Grant SC, Bains M, Rusch V, Rosenzweig KE, Martini N.

Cancer. 1999 Oct 1;86(7):1189-97.

PMID:
10506703
5.

Vindesine-ifosfamide-platinum (VIP) induction chemotherapy in surgically staged IIIA-N2 non-small-cell lung cancer: a prospective study. Leuven Lung Cancer Group.

Vansteenkiste JF, De Leyn PR, Deneffe GJ, Lievens YN, Nackaerts KL, Van Raemdonck DE, van der Schueren E, Lerut TE, Demedts MG.

Ann Oncol. 1998 Mar;9(3):261-7.

PMID:
9602259
6.
7.

Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients.

Martini N, Kris MG, Flehinger BJ, Gralla RJ, Bains MS, Burt ME, Heelan R, McCormack PM, Pisters KM, Rigas JR, et al.

Ann Thorac Surg. 1993 Jun;55(6):1365-73; discussion 1373-4.

PMID:
8390230
8.
9.

Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto Phase II Trial.

Burkes RL, Ginsberg RJ, Shepherd FA, Blackstein ME, Goldberg ME, Waters PF, Patterson GA, Todd T, Pearson FG, Cooper JD, et al.

J Clin Oncol. 1992 Apr;10(4):580-6.

PMID:
1312587

Supplemental Content

Loading ...
Support Center